These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Cyclosporin A. Bright prospects for organ transplantation?]. Dieperink H; Frandsen NE; Kemp E Ugeskr Laeger; 1983 Sep; 145(36):2749-52. PubMed ID: 6356544 [No Abstract] [Full Text] [Related]
25. Interaction between phenytoin and cyclosporine following organ transplantation. Keown PA; Laupacis A; Carruthers G; Stawecki M; Koegler J; McKenzie FN; Wall W; Stiller CR Transplantation; 1984 Sep; 38(3):304-6. PubMed ID: 6474556 [No Abstract] [Full Text] [Related]
26. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation. Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864 [TBL] [Abstract][Full Text] [Related]
28. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Keown PA; Stiller CR; Laupacis AL; Howson W; Coles R; Stawecki M; Koegler J; Carruthers G; McKenzie N; Sinclair NR Transplant Proc; 1982 Dec; 14(4):659-61. PubMed ID: 6762722 [No Abstract] [Full Text] [Related]
29. Some experimental and clinical studies of Cyclosporin A in renal transplantation. Morris PJ Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238 [No Abstract] [Full Text] [Related]
30. [Cyclosporin: experimental studies and clinical use in organ transplants]. Araujo JL; Towpik E; Kupiec-Weglinski JW; Tilney NL Rev Invest Clin; 1984; 36(4):367-76. PubMed ID: 6396785 [No Abstract] [Full Text] [Related]
31. Is cyclosporine-associated nephrotoxicity progressive? Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992 [No Abstract] [Full Text] [Related]
33. [Antibacterial chemotherapy in renal failure]. Briedigkeit H Z Urol Nephrol; 1983 May; 76(5):349-52. PubMed ID: 6880421 [No Abstract] [Full Text] [Related]
34. [Cyclosporin A: a new immunosuppressive agent in renal transplantation]. Martín RS; Thiel G; Brunner F Medicina (B Aires); 1985; 45(6):675-86. PubMed ID: 3916124 [No Abstract] [Full Text] [Related]
35. [Liver transplantation: current status and perspectives]. Pichlmayr R Z Gastroenterol Verh; 1986 Apr; 21():182-9. PubMed ID: 2422835 [No Abstract] [Full Text] [Related]
36. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient. Yogaratnam D; Miller MA; Smith BS Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532 [TBL] [Abstract][Full Text] [Related]
37. Cyclosporine: preliminary experience in 79 patients with renal transplants. Tellis VA; Matas AJ; Glichlick D; Quinn T; Soberman R; Weiss R; Veith FJ N Y State J Med; 1985 Sep; 85(9):531-4. PubMed ID: 3903567 [No Abstract] [Full Text] [Related]
38. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation. Britton K; Atkinson K; Downs K; Biggs J Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501 [No Abstract] [Full Text] [Related]
39. [Cyclosporin: new acquisition in transplant immunosuppression]. Stabile Neto C AMB Rev Assoc Med Bras; 1987; 33(9-10):201-4. PubMed ID: 3333296 [No Abstract] [Full Text] [Related]